Department of Neurology, Jungers Center for Neurosciences Research, Oregon Health and Science University, Portland, Oregon 97239.
Parkinson Center of Oregon, Portland, Oregon 97239.
J Neurosci. 2020 Aug 5;40(32):6234-6249. doi: 10.1523/JNEUROSCI.2809-19.2020. Epub 2020 Jun 30.
The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause of Parkinson's disease (PD) and results in age-related dopamine neuron loss and locomotor dysfunction in through an aberrant increase in bulk neuronal protein synthesis. Under nonpathologic conditions, protein synthesis is tightly controlled by metabolic regulation. Whether nutritional and metabolic influences on protein synthesis can modulate the pathogenic effect of LRRK2 on protein synthesis and thereby impact neuronal loss is a key unresolved question. Here, we show that LRRK2 G2019S-induced neurodegeneration is critically dependent on dietary amino acid content in studies with both sexes. Low dietary amino acid concentration prevents aberrant protein synthesis and blocks LRRK2 G2019S-mediated neurodegeneration in and rat primary neurons. Unexpectedly, a moderately high-amino acid diet also blocks dopamine neuron loss and motor deficits in through a separate mechanism involving stress-responsive activation of 5'-AMP-activated protein kinase (AMPK) and neuroprotective induction of autophagy, implicating the importance of protein homeostasis to neuronal viability. At the highest amino acid diet of the range tested, PD-related neurodegeneration occurs in an age-related manner, but is also observed in control strains, suggesting that it is independent of mutant LRRK2 expression. We propose that dietary influences on protein synthesis and autophagy are critical determinants of LRRK2 neurodegeneration, opening up possibilities for future therapeutic intervention. Parkinson's disease (PD) prevalence is projected to rise as populations continue to age, yet there are no current therapeutic approaches that delay or stop disease progression. A broad role for leucine-rich repeat kinase 2 (LRRK2) mutations in familial and idiopathic PD has emerged. Here, we show that dietary amino acids are important determinants of neurodegeneration in a model of LRRK2 PD. Restricting all amino acids effectively suppresses dopaminergic neuron loss and locomotor deficits and is associated with reduced protein synthesis, while moderately high amino acids similarly attenuate these PD-related phenotypes through a stress-responsive induction of 5'-AMP-activated protein kinase and autophagy. These studies suggest that diet plays an important role in the development of PD-related phenotypes linked to LRRK2.
LRRK2 中的 G2019S 突变是帕金森病 (PD) 的常见病因,通过异常增加神经元整体蛋白合成导致与年龄相关的多巴胺神经元丢失和运动功能障碍。在非病理条件下,蛋白合成受到代谢调节的严格控制。营养和代谢对蛋白合成的影响是否可以调节 LRRK2 对蛋白合成的致病作用,从而影响神经元丢失,这是一个关键的未解决问题。在这里,我们通过雌雄两性的研究表明,LRRK2 G2019S 诱导的神经退行性变严重依赖于饮食中氨基酸的含量。低浓度的饮食氨基酸可防止异常蛋白合成,并阻断 LRRK2 G2019S 介导的 和大鼠原代神经元中的神经退行性变。出乎意料的是,适度高氨基酸饮食也通过涉及应激反应激活 5'-AMP 激活蛋白激酶 (AMPK) 和神经保护性自噬诱导的独立机制阻断 中的多巴胺神经元丢失和运动缺陷,这表明蛋白质平衡对神经元活力的重要性。在所测试的最高氨基酸饮食中,与 PD 相关的神经退行性变以与年龄相关的方式发生,但也在对照品系中观察到,表明它独立于突变 LRRK2 的表达。我们提出,饮食对蛋白合成和自噬的影响是 LRRK2 神经退行性变的关键决定因素,为未来的治疗干预开辟了可能性。随着人口老龄化的继续,帕金森病 (PD) 的患病率预计会上升,但目前还没有可以延缓或阻止疾病进展的治疗方法。LRRK2 突变在家族性和特发性 PD 中具有广泛的作用。在这里,我们表明饮食氨基酸是 LRRK2 PD 模型中神经退行性变的重要决定因素。限制所有氨基酸可有效抑制多巴胺能神经元丢失和运动缺陷,并与蛋白合成减少相关,而适度高氨基酸也通过应激反应诱导 5'-AMP 激活蛋白激酶和自噬来类似地减弱这些与 PD 相关的表型。这些研究表明,饮食在与 LRRK2 相关的 PD 相关表型的发展中起着重要作用。